Strikingly, pharmacologic inhibition of the kinase activity of RIPK1 rescued the majority of Tnfr1KO;Hoil-1E-KO mice from dermatitis for the duration of the treatment with only three of the ten treated mice developing small punctate scales (Fig. 7c–e and Supplementary Fig. 7c). Here, RIPK1 is linked to skin disorder.